# Assessment of EyeArt Performance With Retinal Cameras

> **NCT04984200** · — · COMPLETED · sponsor: **Eyenuk, Inc.** · enrollment: 246 (actual)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **PROCEDURE:** Retinal imaging
- **DRUG:** Mydriatic Agent

## Key facts

- **NCT ID:** NCT04984200
- **Lead sponsor:** Eyenuk, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-13
- **Primary completion:** 2022-08-19
- **Final completion:** 2022-08-19
- **Target enrollment:** 246 (ACTUAL)
- **Last updated:** 2022-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04984200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04984200, "Assessment of EyeArt Performance With Retinal Cameras". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04984200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*